Amedisys, Inc. Profile Avatar - Palmy Investing

Amedisys, Inc.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the ho…
Medical - Care Facilities
US, Baton Rouge [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 0% Bad
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -57.81 57.86 137.16
Graham Fair Price -38.98 18.17 29.79
PEG 114.33 -0.82 0.38
Price/Book -4.61 2.77 2.91
Price/Cash Flow 500.50 -320.05 53.30
Prices/Earnings 166.14 52.42 19.70
Price/Sales -2.78 5.28 5.44
Price/FCF 500.50 -320.05 53.30
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -72.68 0.21 0.75
Operating Margin 53.57 0.09 0.06
ROA -63.95 < 0.005 0.02
ROE 0.04 0.01 -64.16
ROIC 0.03 0.02 -40.19
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.01 < 0.005 -81.43
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.19 0.54 176.58
EPS QOQ 0.51 -0.64 24.17
FCF QOQ 6.27 -1.16 -81.47
Revenue QOQ 0.03 < 0.005 -95.81
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 51.75 56.60 9.38
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.28 0.28 0.33
Quick Ratio 1.00 0.99 -1.06
Naive Interpretation member
04 - Leverage & Liquidity · Bad
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 32.68 33.31 1.92
Cash 4.47 3.69 -17.34
Capex -0.06 -0.09 -37.35
Free Cash Flow 1.78 -0.29 -83.81
Revenue 17.49 17.49 < 0.005
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.05 1.09 3.51
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 13.60 6.18 -54.54
Naive Interpretation Member
06 - Financial Health · Bad
End of AMED's Analysis
CIK: 896262 CUSIP: 023436108 ISIN: US0234361089 LEI: - UEI: -
Secondary Listings
AMED has no secondary listings inside our databases.